Scrip
Clinica
Scrip Regulatory Affairs
Scrip Clinical Research
AnimalPharm
Email ID
Password
Forgotten your password?
Sign me in automatically next time
Advanced Search
Home
Therapy Sector
Generics
Business
Policy & Regulation
Research & Development
International
Legislation
|
Business
|
Products
|
Generics - Business
About Us
Getting Started
Subscribe
Free Trial
Advertise
Awards
White Papers
Executive Briefing
Classifieds
Recruitment
JOB OF THE WEEK
Promote your vacancy here
SCRIP's ONLINE DIRECTORY
Classified ads
LATEST NEWS
US lawmakers, drug makers weigh in on US biosimilars
10 January 2011
Panel urges FDA to reject Novartis gouty arthritis drug on s...
US regulators unveil plan to transform FDA to global agency...
US Senate vote clears way for debate and changes on healthcare reform bill
24 November 2009
Four to five years for the first biogeneric in the US?
09 November 2009
GPhA seeks current biosimilars language struck from US reform bills
29 October 2009
US House panel to debate biosimilars proposal
23 July 2009
>> More News...
LATEST ANALYSIS
2010 Scrip 100 - Can Piramal do a 'Nano' for Indian pharma?
09 December 2009
Market Insight – Managing fraud risks
08 August 2008
>> More Analysis...
LATEST FEATURES
Mixed trends propel consolidation in global generics
15 December 2008
>> More Features...
REFINE BY
COMPANY/ORGANISATION
PFIZER
GLAXOSMITHKLINE
NOVARTIS
ASTRAZENECA
CONDITION
CANCER
DIABETES
PAIN
ARTHRITIS
GEOGRAPHY
JAPAN
INDIA
GERMANY
CHINA
DRUG
AMLODIPINE
SIMVASTATIN
CETUXIMAB
INFLIXIMAB
